{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT02869243: Phase 1 Interventional Completed Glioblastoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:nomlabofusp [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03287908: Phase 1 Interventional Terminated Relapsed/Refractory Multiple Myeloma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04338581: Phase 2 Interventional Active, not recruiting Vitiligo
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04701164: Phase 3 Interventional Completed Guillain-Barre Syndrome
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03486067: Phase 1 Interventional Active, not recruiting Multiple Myeloma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01025206: Phase 1 Interventional Completed Multiple Myeloma
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04680637: Phase 2 Interventional Terminated Active Systemic Lupus Erythematosus
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:tamrintamab pamozirine [INN]
Source URL:
Class:
PROTEIN
